To overcome this, we developed a novel eQTL testing approach, " network-based, large-scale identification o f dis tal eQTL" (NetLIFT), which performs eQTL testing based on the pairwise conditional dependencies between genes' expression levels.
Results from initial tests of this novel examination approach will be ready in late 2013.
Based on extensive simulations, we concluded that the novel biomarker sequential testing approach out-performed other strategies when there was limited prior information for biomarker threshold determination.
Because the MC-MED test is class-dependent, a novel "pre-testing" approach is developed to identify artifacts in real-time classification experiments.
These outcomes suggest that within the scope of this case study, combining the situated Cognitive Engineering approach with a novel testing method addresses various shortcomings of earlier testing methods.
Nevertheless, the possible merits of test combinations in novel multiple test approaches including additional serological markers, might be a promising area for further research.
In developing novel tests for pediatric and EPTB, one approach could be an "optimized" Xpert or other nucleic acid amplification test (NAAT) capable of detecting M. tuberculosis with higher sensitivity in specimens other than sputum (e.g. tissue) for example through improved sample processing and DNA extraction.
With several technological advances, the options for treatment must be carefully weighed and novel approaches tested for safety and efficacy.
Novel approach of testing the borehole heat exchanger was implemented, so called Steady-State Thermal Response Step Testing, which incorporate series of power steps to determine borehole capacity at steady-state heat transfer conditions and thermogeological properties of ground.
To explore heterogeneity in trial findings, we tested a novel approach to integrate qualitative review evidence on patients' perspectives with evidence from a Cochrane systematic review.
